One should consider the primary phase lesion and hemorrhaging that results from mechanical damage during SCI as well as the secondary phase lesion that lasts several hours or even several months and is accompanied by edema, hemorrhage, inflammation, and cytotoxic edema [44,45,46,47] and may extend to the white matter area and lead to white matter degeneration and damage [48, 49]
It also safeguards against blood sugar surges and the dips that follow
Enzymatic characteristics of chimeric mYc/rYc1 glutathione S-transferases
Systemic distribution via abdominal fat pad injection also delivers BPC-157 throughout the body and is effective for general or gut protocols
Insulin dose reduction of 20 to 50% at triple agonist initiation is consistent with the approach used in tirzepatide trials: the SURPASS-5 trial (N=475) reduced insulin glargine by 20% at tirzepatide initiation, which reduced hypoglycemia without sacrificing glycemic control